NCT06028529 is a VA Office of Rehabilitation Research and Development (VA RR&D) sponsored clinical trial investigating the use of a portable/wearable exoskeleton device to improve mobility in patients with Parkinson's disease (PD). This trial represents an important component of the Department of Veterans Affairs' ongoing research into advanced rehabilitation technologies for veterans with neurological conditions.
¶ Background and Rationale
Parkinson's disease affects approximately 1 million Americans, with veterans at particularly elevated risk due to potential exposures during military service. The disease progressively impairs motor function, leading to gait disturbances, bradykinesia, freezing of gait, and increased fall risk. Traditional pharmacological and surgical interventions address dopaminergic symptoms but often provide incomplete relief for gait and mobility impairment.
Portable exoskeletons represent a emerging rehabilitation technology that can provide mechanical assistance during walking and standing activities. Unlike stationary rehabilitation robots used in clinical settings, portable exoskeletons are designed for more natural use in everyday environments. The theoretical basis for their benefit in PD includes:
- External mechanical cueing: The rhythmic support provided by the exoskeleton may help "reset" dysfunctional motor patterns in the basal ganglia
- Reduced physical burden: Assists patients with bradykinesia in generating adequate stepping movements
- Training effects: Enables high-intensity, repetitive gait practice that promotes neuroplasticity
- Fall prevention: Provides stability support during ambulation
The trial evaluates a portable lower extremity exoskeleton designed for ambulation assistance in Parkinson's disease. Unlike traditional rehabilitation exoskeletons used in clinical settings (such as ReWalk, EksoGT, or Indego), portable devices are designed to be worn during daily activities, potentially extending therapeutic benefit beyond formal training sessions.
Key device characteristics may include:
- Motorized assistance at hip and/or knee joints
- Sensor systems to detect user movement intention
- Battery-powered operation for untethered use
- Adjustable assistance levels based on patient needs
- Lightweight frame to minimize metabolic burden
As a VA-sponsored trial, this study likely employs a controlled design to evaluate both safety and efficacy. Typical designs for exoskeleton trials in PD include:
- Baseline vs. intervention comparisons: Pre-post assessments with the device vs. without
- Dose-response evaluation: Different training durations or device settings
- Control group: Conventional physical therapy vs. exoskeleton-assisted training
Based on the VA rehabilitation research focus, participants likely include:
- Parkinson's disease diagnosis (various Hoehn and Yahr stages)
- Gait impairment sufficient to warrant intervention
- Ability to stand and attempt walking with or without assistive devices
- Cognitive capacity to follow study instructions
- Medical clearance for ambulation activities
- Veterans (primary population) or VA healthcare enrollees
Primary outcomes likely include:
- Walking velocity (m/s)
- Stride length (m)
- Cadence (steps/min)
- Timed Up and Go (TUG) time
- 6-Minute Walk Test distance
- Unified Parkinson's Disease Rating Scale (UPDRS) motor subscore
- Freezing of Gait Questionnaire (FOG-Q)
- Berg Balance Scale
- Falls frequency
- PD Quality of Life (PDQ-39)
- Gait-specific self-efficacy measures
- Subjective mobility ratings
This trial addresses several important gaps in PD rehabilitation:
¶ Current Limitations of Standard Therapy
Standard physical therapy for PD is limited by:
- Therapist availability and session duration
- Difficulty translating gym-based improvements to home environments
- Progressive functional decline between sessions
- Limited options for severe gait impairment
Portable exoskeletons could address these limitations by:
- Enabling continuous mobility assistance throughout the day
- Providing consistent mechanical cueing during real-world ambulation
- Reducing fall risk during daily activities
- Promoting ongoing functional training in natural environments
- Supporting independence and quality of life
This trial builds on foundation established by prior exoskeleton research in PD:
- Studies demonstrating improved gait kinematics with powered exoskeletons in PD patients [@exoskelPD]
- Systematic reviews confirming benefits for gait velocity, stride length, and balance [@neuroPDATrial]
- Research exploring home-based rehabilitation robotics applications [@portableRehab]
- FDA clearance pathways for lower extremity exoskeletons [@fdaExoskel]
This clinical trial relates to several key NeuroWiki topics:
Regardless of trial outcome, this research will contribute to understanding:
- Optimal device designs for PD-specific mobility needs
- Best practices for integrating exoskeletons into PD rehabilitation
- Patient selection criteria for portable exoskeleton use
- Long-term outcomes and adherence considerations
- Cost-effectiveness and insurance coverage pathways
NCT06028529 represents an important research initiative into portable exoskeleton technology for Parkinson's disease mobility. As the veteran population ages and PD prevalence increases, VA-sponsored research into advanced rehabilitation technologies becomes increasingly significant. Positive results could expand treatment options for the millions of Americans living with Parkinson's disease.
- Unknown, VA Rehabilitation Research and Development Service (n.d.)
- Unknown, Exoskeleton-Assisted Gait Training in Parkinson's Disease: Effects on Gait Kinematics (n.d.)
- Unknown, Robot-Assisted Gait Training in Parkinson's Disease: Systematic Review (n.d.)
- Unknown, Home-Based Robotic Rehabilitation: Challenges and Opportunities (n.d.)
- Unknown, FDA Clears Wearable Robotic Exoskeleton for Lower Extremity (n.d.)